BackDyne Therapeutics Overview
Dyne Therapeutics Inc

Dyne Therapeutics Target Price

Analysts' 12-month price predictions for DYN.

Get informed when a big investor buys or sells

+ Follow

Share Price

$23.78

Average Target Price

$28.5019.8% upside

2 analysts in the last 4 months

High: $33 | Low: $24

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-15Evercore ISI$3338.8% upsideOpen
2026-05-13Bernstein$240.9% upsideOpen
2026-03-02Chardan CapitalKeay Nakae$3859.8% upsideOpen
2026-03-02Morgan StanleyMichael E Ulz$4797.6% upsideOpen
2025-12-15Evercore ISIGavin Clark-Gartner$3651.4% upsideOpen
2025-12-11Stifel Nicolaus$3964% upsideOpen
2025-12-10Oppenheimer$4068.2% upsideOpen
2025-12-09Tudor PickeringWilliam Pickering$233.3% downsideOpen
2025-12-09Bernstein$233.3% downsideOpen
2025-12-08Morgan StanleyMichael E Ulz$50110.3% upsideOpen
2025-12-08Robert W. BairdBrian Skorney$3026.2% upsideOpen
2025-12-08H.C. WainwrightAndrew Fein$60152.3% upsideOpen
2025-12-08Raymond JamesMichael Freeman$4068.2% upsideOpen
2025-11-25Bernstein$2111.7% downsideOpen
2025-11-06Evercore ISIGavin Clark-Gartner$3859.8% upsideOpen
2025-10-10Oppenheimer$1345.3% downsideOpen
2025-08-25Raymond JamesStrong Buy$3547.2% upsideOpen
2025-06-02OppenheimerAndreas Argyrides$3443% upsideOpen
2025-02-28UBS$48101.9% upsideOpen
2025-02-28H.C. Wainwright$4693.4% upsideOpen
2024-08-14Morgan StanleyMichael Ulz$52118.7% upsideOpen
2024-08-13Piper SandlerEdward Tenthoff$53122.9% upsideOpen
2024-06-24JefferiesEun Yang$4276.6% upsideOpen
2024-06-17OppenheimerFrancois Brisebois$55131.3% upsideOpen
2024-05-21Chardan CapitalKeay Nakae$4276.6% upsideOpen
2024-05-20H.C. WainwrightAndrew Fein$48101.9% upsideOpen
2024-05-20Stifel NicolausPaul Matteis$4172.4% upsideOpen
2024-04-30Morgan StanleyMichael Ulz$4068.2% upsideOpen
2022-11-29J.P. Morgan$1824.3% downsideOpen
2022-09-06Piper SandlerEdward Tenthoff$233.3% downsideOpen
2022-07-12Piper SandlerEdward Tenthoff$1728.5% downsideOpen